These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8364742)

  • 1. Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeys.
    Schneider JS; Roeltgen DP
    Brain Res; 1993 Jul; 615(2):351-4. PubMed ID: 8364742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys.
    Schneider JS; Kovelowski CJ
    Brain Res; 1990 Jun; 519(1-2):122-8. PubMed ID: 2397401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys.
    Schneider JS; Tinker JP; Van Velson M; Menzaghi F; Lloyd GK
    J Pharmacol Exp Ther; 1999 Aug; 290(2):731-9. PubMed ID: 10411585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the nicotinic acetylcholine receptor agonist SIB-1508Y on object retrieval performance in MPTP-treated monkeys: comparison with levodopa treatment.
    Schneider JS; Van Velson M; Menzaghi F; Lloyd GK
    Ann Neurol; 1998 Mar; 43(3):311-7. PubMed ID: 9506547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys.
    Slovin H; Abeles M; Vaadia E; Haalman I; Prut Y; Bergman H
    J Neurophysiol; 1999 Feb; 81(2):858-74. PubMed ID: 10036286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey.
    Schneider JS; Pope-Coleman A
    Neurodegeneration; 1995 Sep; 4(3):245-55. PubMed ID: 8581557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Task persistence and learning ability in normal and chronic low dose MPTP-treated monkeys.
    Roeltgen DP; Schneider JS
    Behav Brain Res; 1994 Feb; 60(2):115-24. PubMed ID: 8003241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys.
    Taylor JR; Elsworth JD; Roth RH; Sladek JR; Redmond DE
    Brain; 1990 Jun; 113 ( Pt 3)():617-37. PubMed ID: 2364263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in alpha7 nicotinic acetylcholine receptor binding in motor symptomatic and asymptomatic MPTP-treated monkeys.
    Kulak JM; Schneider JS
    Brain Res; 2004 Mar; 999(2):193-202. PubMed ID: 14759498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the prolyl endopeptidase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys.
    Schneider JS; Giardiniere M; Morain P
    Neuropsychopharmacology; 2002 Feb; 26(2):176-82. PubMed ID: 11790513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine.
    Tabbal SD; Mink JW; Antenor JA; Carl JL; Moerlein SM; Perlmutter JS
    Neuroscience; 2006 Sep; 141(3):1281-7. PubMed ID: 16766129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier.
    Taylor JR; Roth RH; Sladek JR; Redmond DE
    Behav Neurosci; 1990 Aug; 104(4):564-76. PubMed ID: 2206426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys.
    Schneider JS; Sun ZQ; Roeltgen DP
    Brain Res; 1994 Nov; 663(1):140-4. PubMed ID: 7850462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic exposure to low doses of MPTP. II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeys.
    Schneider JS
    Brain Res; 1990 Nov; 534(1-2):25-36. PubMed ID: 2073585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nicotinic therapies on attention and executive functions in chronic low-dose MPTP-treated monkeys.
    Decamp E; Schneider JS
    Eur J Neurosci; 2006 Oct; 24(7):2098-104. PubMed ID: 17067307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the partial glycine agonist D-cycloserine on cognitive functioning in chronic low dose MPTP-treated monkeys.
    Schneider JS; Tinker JP; Van Velson M; Giardiniere M
    Brain Res; 2000 Mar; 860(1-2):190-4. PubMed ID: 10727642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian determinations of cortisol, prolactin and melatonin in chronic methyl-phenyl-tetrahydropyridine-treated monkeys.
    Barcia C; Bautista V; Sánchez-Bahillo A; Fernández-Villalba E; Navarro-Ruis JM; Barreiro AF; Poza Y Poza M; Herrero MT
    Neuroendocrinology; 2003 Aug; 78(2):118-28. PubMed ID: 12915764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The subtype-selective nicotinic acetylcholine receptor agonist SIB-1553A improves both attention and memory components of a spatial working memory task in chronic low dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
    Schneider JS; Tinker JP; Menzaghi F; Lloyd GK
    J Pharmacol Exp Ther; 2003 Jul; 306(1):401-6. PubMed ID: 12721323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Pflibsen L; Stang KA; Sconce MD; Wilson VB; Hood RL; Meshul CK; Mitchell SH
    J Neurosci Res; 2015 Dec; 93(12):1849-64. PubMed ID: 26332770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.